The OKR Podcast AI Now or Never
Feb 18, 2026
Lisa Om, VP of Marketing at USDM Life Sciences who helps life sciences companies adopt tech, compliance, and AI. She discusses where to begin the AI journey and why starting now matters. Topics include AI’s impact on workflows and governance. She outlines starting with a single business problem, data readiness, involving quality and IT early, and using small wins to drive wider adoption.
AI Snips
Chapters
Transcript
Episode notes
WorkBoard Became Their Remote North Star
- USDM adopted WorkBoard in 2018 to drive strategy, alignment, and execution across a remote company.
- The tool became their workflow backbone and kept teams focused during rapid pandemic-driven growth.
AI Means Speed Plus Regulatory Risk
- AI can massively speed drug discovery, trials, manufacturing, and supply chain decisions in life sciences.
- That speed sits alongside high regulatory risk and unknowns around data handling.
Start AI With Data And A Small Pilot
- Assess your data health, governance, and digital maturity before launching AI projects.
- Define the business problem you want to solve and pick a small, testable pilot first.